Life-style and genital human papillomavirus in a cross-sectional survey in Shanxi Province, China

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 3, 2011, Pages 781-786

  Zou, Lily ^a   Bao, Yan Ping ^b,c   Li, Ni ^b   Dai, Min ^d   Ma, Cong Ping ^e   Zhang, Yong Zhen ^f   Liu, Xin Fu ^b   Feinleib, Manning ^g   Qiao, You Lin ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b CANCER HOSPITAL   (China)

^c PEKING UNIVERSITY   (China)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e Yangcheng Cancer Institute/Hospital   (China)

^f SHANXI CANCER HOSPITAL   (China)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Age stratified; Bathing; China; Human papillomavirus (HPV); Prevalence rate

Indexed keywords

EID: 79958821310     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Belinson JL, Qiao YL, Pretorius RG, et al.(2003). Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology. Int J Gynecol Cancer, 13, 819-26.
2. Bosch FX, Manos MM, Munoz N, et al.(1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst, 87, 796-802.
3. Burk RD, Kelly P, Feldman J, et al.(1996). Declining Prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis, 23, 333-41.
4. Castellsague X, Diaz M, de Sanjose S, et al.(2006). Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst, 98, 303-15.
5. Dai M, Bao YP, Li N, et al.(2006). Human papillomavirus infection in Shanxi province, People's Republic of China: a population-based study. Br J Cancer, 95, 96-101.
6. Ferreccio C, Prado RB, Luzoro AV, et al.(2004). Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev, 13, 2271-6.
7. Franceschi S, Rajkumar T, Vaccarella S, et al.(2003). Human papillomavirus and risk factors for cervical cancer in chennai, India: a case-control study. Int J Cancer, 107, 127-33.
8. Hammouda D, Munoz N, Herrero R, et al.(2004). Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors. Int J Cancer, 111, 278-85.
9. Harper DM, Franco EL, Wheeler C, et al.(2004). Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet, 364, 1757-65.
10. Jeng CJ, Ko ML, Ling QD, et al.(2005). Prevalence of cervical human papillomavirus in Taiwanese women. Clin Invest Med, 28, 261-.
11. Kataja V, Syrjanen S, Yliskoski M, et al.(1993). Risk factors associated with cervical human papillomavirus infections: a case-control study. Am J Epidemiol, 138, 735-45.
12. Kamaluddin M.(1999). Cancer cervix - a retrospective study. J Prev Soc Med, 18, 30-4.
13. Li LK, Dai M, Clifford GM, et al.(2006). Human papillomavirus infection in Shenyang city, people's Republic of China: a population-based study. Br J Cancer, 95, 1593-7.
14. Munoz N, Kato I, Bosch FX, et al.(1996). Risk factors for HPV DNA detection in middle-aged women. Sex Transm Dis; 23, 504-10
15. Munoz N, Bosch FX, de Sanjos S, et al.(2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 384, 518-27.
16. Parkin DM, Bray F, Ferlay J, et al.(2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
17. Peto J, Gilham C, Deacon J, et al.(2004). Cervical HPV infection and neoplasia in a large population-based prospective study: the manchester cohort. Br J Cancer, 91, 942-53.
18. Sellors JW, Karwalajtys TL, Kaczorowski JA, et al.(2002). Prevalence of infection with carcinogenic human papillomavirus among older women. CMAJ, 167, 871-3.
19. Sellors JW, Karwalajtys TL, Kaczorowski J, et al.(2003). Survey of HPV in ontario women group. incidence, clearance and predictors of human papillomavirus infection in women. CMAJ, 168, 421-5.
20. Shen YH, Chen F, Huang MN, et al.(2003). Population-based study of human papillomavirus infection in high-risk area for cervical cancer in Shanxi province, China. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 25, 381-5.
21. Walboomers JMM, Jacobs MV, Manos MM, et al.(1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.
22. Wu RF, Dai M, Qiao YL, et al.(2007). Human papillomavirus infection in women in Shenzhen city, people's republic of China, a population typical of recent chinese urbanisation. Int J Cancer, 121, 1306-11.
23. Zhao FH, Forman MR, Belinson J, et al.(2006). Risk factors for HPV infection and cervical cancer among unscreened women in a high-risk rural area of China. Int J Cancer, 118, 442-8.
24. Zhang ZF, Parkin DM, Yu SZ, et al.(1989). Risk factors for cancer of the cervix in a rural Chinese population. Int J Cancer, 43, 762-.